Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

iShares Biotechnology ETF Stock News

IBBNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$130.29

-1.29-0.98%

At close: -

$131.14

0.850.65%

After Hours: Mar 26, 4:05 PM EDT

News

Holdings Dividends Short Interest

Latest iShares Biotechnology ETF News | NASDAQ:IBB | Benzinga

Get the latest news on iShares Biotechnology ETF stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on iShares Biotechnology ETF performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, February 24, 2025

NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Rishabh Mishra

Friday, January 31, 2025

Trump Says He Wants To Bring Pharmaceuticals ...
Benzinga Newsdesk

Thursday, January 09, 2025

Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ
Rishabh Mishra

Monday, November 18, 2024

Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades'
Avi Kapoor

Thursday, November 14, 2024

Elliott Investment Management 13F Shows Exite...
Benzinga Newsdesk

Wednesday, July 31, 2024

Should You Invest in the iShares Biotechnology ETF?
Zacks

Monday, July 01, 2024

Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
Piero Cingari

Friday, June 21, 2024

Stocks Stall As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday?
Piero Cingari

Tuesday, April 30, 2024

April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
Piero Cingari

Monday, January 29, 2024

AI, Biotech, Energy Sectors Expect M&A Revival For 2024
Neil Dennis

Friday, January 05, 2024

Live On CNBC, Jason Snipe's Contrarian Idea: ...
Benzinga Newsdesk

Wednesday, January 03, 2024

US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday?
Piero Cingari

Tuesday, January 02, 2024

Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday?
Piero Cingari

Friday, December 29, 2023

Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback
Surbhi Jain

Tuesday, December 26, 2023

Wall Street Sees Post-Holiday Gains, Oil Rallies, Intel Leads: What's Driving Markets Tuesday?
Piero Cingari

Friday, December 22, 2023

S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday?
Piero Cingari

Thursday, December 21, 2023

US Stocks Bounce; Chipmakers, Cruise Lines Lead, Dollar Falls: What's Driving Markets Thursday?
Piero Cingari

Wednesday, December 20, 2023

Wall Street Edges Higher, Small Caps Eye Best Month In 3 Years, Bitcoin Rebounds: What's Driving Markets Wednesday?
Piero Cingari

Tuesday, November 07, 2023

Activist Investor Elliott Pushes for Strategy Revamp at BioMarin Amid CEO Change
Vandana Singh

Thursday, August 31, 2023

Industry ETFs In The Spotlight: August's Winners And Losers Revealed: Where Is Gold, Energy And Biotech?
Piero Cingari

Saturday, August 12, 2023

Weight-Loss Drug Wegovy Adds Mass To Novo Nordisk's stock, Pushing Valuation Past Denmark's GDP
Shanthi Rexaline

Thursday, August 10, 2023

Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss
Piero Cingari

Monday, July 31, 2023

Rising Stars, Falling Trends: July's Industry ETF Winners And Losers
Piero Cingari

Thursday, April 13, 2023

Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Vandana Singh
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Vandana Singh

Wednesday, April 12, 2023

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Vandana Singh

Tuesday, April 11, 2023

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Vandana Singh

Thursday, April 06, 2023

FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Vandana Singh
AbbVie, Thermo Fisher Scientific And A Must-Watch Biotech ETF: CNBC's 'Final Trades'
Lisa Levin

Thursday, March 16, 2023

US Judge Weighs Nationwide Ban On Abortion Pills
Vandana Singh

Monday, March 13, 2023

Silicon Valley Bank Meltdown Hits Healthcare Sector As Well
Vandana Singh

Friday, March 10, 2023

Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
Vandana Singh
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
Vandana Singh

Wednesday, March 08, 2023

Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births
Vandana Singh
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
Vandana Singh

Wednesday, March 01, 2023

FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Vandana Singh

Monday, February 20, 2023

Man in Germany Cured of HIV After Undergoing Stem Cell Transplant, According to Report in Nature Medicine
Charles Gross

Tuesday, January 31, 2023

February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
Shanthi Rexaline

Friday, January 06, 2023

Longeveron Shares Surge Following FDA Decisio...
Benzinga Newsdesk
SAVA, LLY, IBB: Why These Alzheimer's Related...
Benzinga Newsdesk

Tuesday, December 27, 2022

Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Shanthi Rexaline

Monday, December 05, 2022

Meta Platforms, This Biotech ETF And These China Plays Are CNBC's 'Final Trades'
Priya Nigam

Friday, December 02, 2022

Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
Shanthi Rexaline

Thursday, December 01, 2022

BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
Faith Ashmore - Sponsored

Tuesday, November 01, 2022

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
Shanthi Rexaline

Thursday, October 27, 2022

These 4 ETFs Feature on CNBC's 'Final Trades'
Priya Nigam

Sunday, October 02, 2022

AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
Shanthi Rexaline

Wednesday, August 31, 2022

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
Shanthi Rexaline

Wednesday, August 10, 2022

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
Vandana Singh

Tuesday, August 09, 2022

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Vandana Singh

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved